AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Chymosia AP 100mg/325mg Tablet

Prescription Icon
Prescription Required

Marketer

Avosia Pharma

Salt Composition

Aceclofenac (100mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000IU)

Overview Chymosia AP 100mg/325mg Tablet

Anavil AP 100mg/325mg tablets provide pain relief. Indicated for pain and inflammation associated with conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, it also offers relief from muscle aches, back pain, dental pain, and ear, nose, and throat discomfort. Always take Anavil AP with food to minimize stomach upset. Dosage and treatment length vary depending on individual needs and response; strictly follow your physician's instructions. Avoid exceeding the prescribed dose or duration. Common side effects include nausea, vomiting, heartburn, abdominal pain, and dyspepsia. Report persistent or worsening side effects to your doctor, who may offer management strategies. Prior to use, inform your doctor of any history of stomach ulcers or bleeding, hypertension, or pre-existing heart, kidney, or liver conditions. Disclose all other medications to ensure safe concurrent use. Pregnant or lactating individuals should seek medical advice before commencing treatment. Alcohol consumption should be avoided during treatment due to the risk of increased drowsiness.

Primary Ingredients of Chymosia AP 100mg/325mg Tablet

No text provided to rephrase.

Uses of Chymosia AP 100mg/325mg Tablet

Analgesia

Major Benefits of Chymosia AP 100mg/325mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Chymosia AP 100mg/325mg Tablet with a meal.

Common Side effects of Chymosia AP 100mg/325mg Tablet:

  • Nausea
  • Vomiting
  • Heartburn
  • Stomach pain
  • Indigestion
  • Loss of appetite
  • Diarrhea

How to use Chymosia AP 100mg/325mg Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Chymosia AP 100mg/325mg tablets with a meal.

How Chymosia AP 100mg/325mg Tablet works:

Each Chymosia AP 100mg/325mg tablet unites aceclofenac, paracetamol, and trypsin-chymotrypsin to alleviate pain. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), and the antipyretic paracetamol, curtail the production of pain and fever-inducing brain chemicals. The enzymatic duo, trypsin and chymotrypsin, degrade proteins, facilitating their absorption and boosting blood flow to reduce inflammation in the affected region.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Chymosia AP 100mg/325mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Chymosia AP 100mg/325mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Chymosia AP 100mg/325mg tablets with breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Chymosia AP 100mg/325mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Chymosia AP 100mg/325mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Chymosia AP 100mg/325mg tablets are contraindicated in individuals with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when taking Chymosia AP 100mg/325mg tablets, potentially requiring dose modification. A physician's consultation is advised. Chymosia AP 100mg/325mg tablets are contraindicated for individuals experiencing severe or active liver disease.

What if you forget to take Chymosia AP 100mg/325mg Tablet :

Should you forget a Chymosia AP 100mg/325mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Chymosia AP 100mg/325mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Pain relievers

FAQs on Chymosia AP 100mg/325mg Tablet

Aceclofenac, paracetamol, trypsin, and chymotrypsin are combined in Chymosia AP 100mg/325mg tablets. This formulation reduces pain and inflammation by lowering the concentration of pain- and inflammation-causing compounds within the body.
Patient addiction to Chymosia AP 100mg/325mg tablets has not been reported.
The 100mg/325mg Chymosia AP tablet is typically prescribed for short-term use, ceasing once pain subsides. Nevertheless, continue taking the 100mg/325mg Chymosia AP tablet if directed by your physician.
Dizziness, including faintness, weakness, unsteadiness, or lightheadedness, is a potential side effect of Chymosia AP 100mg/325mg Tablets in certain individuals. Should dizziness occur, temporary rest is recommended before resuming activity.
Chronic ingestion of Chymosia AP 100mg/325mg tablets can indeed compromise renal function. The kidneys naturally produce prostaglandins, chemicals that safeguard against damage. Analgesic consumption diminishes prostaglandin levels, thereby increasing the risk of kidney injury with prolonged use. Individuals with pre-existing kidney conditions should avoid using such painkillers.
Each Chymosia AP 100mg/325mg tablet incorporates paracetamol. Excessive paracetamol consumption can be hepatotoxic. Concurrent alcohol use while taking this medication elevates the risk of liver injury. Individuals with pre-existing liver conditions should ideally refrain from using this medicine. Report any potential signs of liver damage—including fever, skin rash, anorexia, nausea, emesis, lassitude, abdominal pain, dark urine, jaundice, and atypical liver function tests—to your physician promptly.
Pain relief from Chymosia AP 100mg/325mg Tablet may become noticeable within approximately one hour.
Should you miss a scheduled dose of Chymosia AP 100mg/325mg Tablet, and your next dose is imminent, omit the missed dose and proceed with your regular schedule. If, however, sufficient time remains before your next dose, take the medication immediately upon recollection, then resume your usual dosing regimen. Avoid doubling the dose to compensate for a missed one, as this elevates the likelihood of adverse reactions. For any uncertainty regarding missed doses, seek guidance from your physician.
Increasing your medication dosage beyond the prescribed amount won't necessarily improve results; instead, it could heighten the risk of severe adverse reactions and harmful effects. If your symptoms worsen despite taking the recommended dose, seek medical advice for reassessment.
Patients with hypersensitivity to Chymosia AP 100mg/325mg Tablet components or inactive ingredients should not take this medication. Individuals with a history of peptic ulcers, active or recurrent stomach ulcers/bleeding, heart failure, hypertension, or hepatic or renal impairment should generally refrain from using this drug.
Chymosia AP 100mg/325mg T...
98
MRP 120
18% off